Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline Magnesium Trisalicylate in AML Induction
NCT02144675Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Jan 2009
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of choline magnesium trisalicylate in acute myeloid leukemia (AML), sponsored by Rutgers University. Started Jan 2009; status: completed.
02
Drugs
choline magnesium trisalicylate
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02144675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144675.